How many insider trades does FilingIQ track for QTTB?

FilingIQ tracks 33 Form 4 insider transactions for QTTB (Q32 Bio Inc.), covering filings from Mar 25, 2024 onwards. 6 of those were filed in the last 90 days.

Are QTTB insiders net buyers or net sellers?

Across the full Form 4 history for QTTB, 0 transactions (0%) were open-market purchases and 11 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does QTTB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is QTTB in?

Q32 Bio Inc. (QTTB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $50.08M.

QTTB insider trading

Healthcare

Q32 Bio Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 33%

Market cap

$50.08M

About Q32 Bio Inc.

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.

Company website: www.q32bio.com

QTTB insider activity at a glance

FilingIQ has scored 33 insider transactions for QTTB since Mar 25, 2024. The most recent filing in our index is dated Feb 25, 2026.

Across the full history, 0 open-market purchases and 11 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on QTTB insider trades is 62.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live QTTB trades on FilingIQ Raw filings on SEC EDGAR

Latest QTTB Form 4 filings

Morrison Jodie Pope CEO

S Dec 2, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading QTTB

Morrison Jodie Pope

3 trades · score 70.5

Frequently asked

How many insider trades does FilingIQ track for QTTB?: FilingIQ tracks 33 Form 4 insider transactions for QTTB (Q32 Bio Inc.), covering filings from Mar 25, 2024 onwards. 6 of those were filed in the last 90 days.
Are QTTB insiders net buyers or net sellers?: Across the full Form 4 history for QTTB, 0 transactions (0%) were open-market purchases and 11 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does QTTB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is QTTB in?: Q32 Bio Inc. (QTTB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $50.08M.

Methodology & sources

Every QTTB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.